Ovarian Cancer Clinical Trial

Clinical Trial Finder Ovarian Cancer Trials

High-dose Periop Statins for Prevention of DVT

See Locations Near You

Summary

This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce inflammatory responses and deep vein thrombosis formation when given in high doses in the perioperative period.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

gynecologic tumor scheduled for resection

Exclusion Criteria:

prior reaction to statins
renal insufficiency
liver disease
h/o alcoholism
prior h/o DVT or hypercoagulability
concurrent medications that significantly affect cytochrome P450 3A4
breast feeding or pregnancy

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

29

Study ID:

NCT00259662

Recruitment Status:

Completed

Sponsor:

Yale University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Yale-New Haven Hospital
New Haven Connecticut, 06510, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

29

Study ID:

NCT00259662

Recruitment Status:

Completed

Sponsor:


Yale University

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Promising Immunotherapy Trials for Ovarian Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider